Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis
- 2 June 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 91 (8) , 1055-1060
- https://doi.org/10.1002/bjs.4593
Abstract
Background: Many studies have attempted to detect cancer cells using the reverse transcription–polymerase chain reaction (RT–PCR) for specific mRNAs. None has examined the correlation between the presence of circulating oesophageal cancer cells in peripheral blood and long‐term outcome. Methods: Blood samples were obtained on admission, and before, during and after operation from 70 patients with squamous oesophageal cancer who had complete clinicopathological records and who underwent curative oesophagectomy between June 1997 and June 2000. RT–PCR for mRNA encoding squamous cell carcinoma antigen (SCCA mRNA) was used to detect oesophageal cancer cells in peripheral blood. Results: Twenty‐three patients (33 per cent) were positive for SCCA mRNA on admission and 17 of these patients developed recurrent disease. SCCA mRNA on admission correlated with the depth of tumour invasion (P < 0·001) and with venous invasion (P < 0·001). Eleven of 24 patients with a positive intraoperative result were positive for SCCA mRNA only during operation, of whom seven also developed recurrence. Conclusion: RT–PCR for SCCA mRNA can detect oesophageal cancer cells in peripheral blood. The presence of such cells in blood samples obtained on admission or during operation is a useful predictor of outcome in patients with oesophageal squamous cell carcinoma. Copyright © 2004 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.Keywords
Funding Information
- Japanese Ministry of Education, Science and Culture (09671301)
- Cancer Research Ministry of Health and Welfare (10-3)
This publication has 19 references indexed in Scilit:
- Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancerSurgery, 2003
- Bone marrow—disseminated tumor cells in patients with carcinoma of the esophagus or cardiaSurgery, 2001
- Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivityEuropean Journal Of Cancer, 2000
- RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parametersBreast Cancer Research and Treatment, 2000
- Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNABritish Journal of Cancer, 2000
- Molecular detection of circulating cancer cells during surgery in patients with biliary-pancreatic cancerThe American Journal of Surgery, 1999
- The sequence of vessel ligation affects tumor release into the circulationThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20International Journal of Cancer, 1998
- Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervixInternational Journal of Cancer, 1997
- Micrometastases in bone marrow of patients undergoing “curative” surgery for gastrointestinal cancerGastroenterology, 1995